drug summary · 3 NDC codes
QUDEXY XR 150 mg/1
Topiramate
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | Topiramate |
|---|---|
| active ingredients | TOPIRAMATE |
| dosage form | CAPSULE, EXTENDED RELEASE |
| route | ORAL |
| strength | 150 mg/1 |
| marketing status | NDA |
| DEA schedule | not reported |
| application number | NDA205122 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | Upsher-Smith Laboratories, LLC |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE] |
NDC codes
3 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 00245107530 | — |
| 00245107590 | — |
| 0245-1075 | — |
Other Topiramate products
14 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.
- QUDEXY XR 100 mg/1CAPSULE, EXTENDED RELEASE · Upsher-Smith Laboratories, LLC
- Topamax 100 mg/1TABLET, COATED · Janssen Pharmaceuticals, Inc.
- Trokendi XR 100 mg/1CAPSULE, EXTENDED RELEASE · Supernus Pharmaceuticals, Inc.
- Topamax 15 mg/1CAPSULE, COATED PELLETS · Janssen Pharmaceuticals, Inc.
- QUDEXY XR 200 mg/1CAPSULE, EXTENDED RELEASE · Upsher-Smith Laboratories, LLC
- Topamax 200 mg/1TABLET, COATED · Janssen Pharmaceuticals, Inc.
- Trokendi XR 200 mg/1CAPSULE, EXTENDED RELEASE · Supernus Pharmaceuticals, Inc.
- QUDEXY XR 25 mg/1CAPSULE, EXTENDED RELEASE · Upsher-Smith Laboratories, LLC
- Topamax 25 mg/1TABLET, COATED · Janssen Pharmaceuticals, Inc.
- Topamax 25 mg/1CAPSULE, COATED PELLETS · Janssen Pharmaceuticals, Inc.
- Trokendi XR 25 mg/1CAPSULE, EXTENDED RELEASE · Supernus Pharmaceuticals, Inc.
- QUDEXY XR 50 mg/1CAPSULE, EXTENDED RELEASE · Upsher-Smith Laboratories, LLC
2 more are listed in the drug product index.
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.